Coarelli G, Wirth T, Tranchant C, Koenig M, Durr A, Anheim M. The inherited cerebellar ataxias: an update. J Neurol. 2023;270(1):208–22.

Article  PubMed  Google Scholar 

Vankan P. Prevalence gradients of Friedreich’s ataxia and R1b haplotype in Europe co-localize, suggesting a common Palaeolithic origin in the Franco-Cantabrian ice age refuge. J Neurochem. 2013;126(Suppl 1):11–20.

Article  CAS  PubMed  Google Scholar 

Pandolfo M. Friedreich ataxia: the clinical picture. J Neurol. 2009;256(Suppl 1):3–8.

Article  PubMed  Google Scholar 

Rojas P, Ramírez AI, Hoz R, et al. Ocular involvement in friedreich ataxia patients and its relationship with neurological disability, a follow-up study. Diagnostics (Basel). 2020;10(2):75.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schulz JB, Boesch S, Bürk K, et al. Diagnosis and treatment of Friedreich ataxia: a European perspective. Nat Rev Neurol. 2009;5(4):222–34.

Article  PubMed  Google Scholar 

Bürk K. Friedreich ataxia: current status and future prospects. Cerebellum Ataxias. 2017;4:4.

Article  PubMed  PubMed Central  Google Scholar 

Hanson E, Sheldon M, Pacheco B, Alkubeysi M, Raizada V. Heart disease in Friedreich’s ataxia. World J Cardiol. 2019;11(1):1–12.

Article  PubMed  PubMed Central  Google Scholar 

Cortese A, Simone R, Sullivan R, et al. Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia. Nat Genet. 2019;51(4):649–58.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bogdanova-Mihaylova P, Hebert J, Moran S, et al. Inherited cerebellar ataxias: 5-year experience of the Irish National Ataxia Clinic. Cerebellum. 2021;20(1):54–61.

Article  CAS  PubMed  Google Scholar 

Malaquias MJ, Braz L, Santos Silva C, et al. Multisystemic RFC1-related disorder: expanding the phenotype beyond cerebellar ataxia, neuropathy, and vestibular areflexia syndrome. Neurol Clin Pract. 2023;13(5):e200190.

Article  PubMed  Google Scholar 

World Health Organization, et al. Programme on mental health: WHOQOL user manual. (No. WHO/HIS/HSI Rev. 2012.03). Geneva, Switzerland: World Health Organization; 1998.

Karimi M, Brazier J. Health, health-related quality of life, and quality of life: what is the difference? Pharmacoeconomics. 2016;34(7):645–9.

Article  PubMed  Google Scholar 

Sánchez-López CR, Perestelo-Pérez L, Escobar A, López-Bastida J, Serrano-Aguilar P. Health-related quality of life in patients with spinocerebellar ataxia. Neurología (English Edition). 2017;32(3):143–51.

Article  Google Scholar 

Tai G, Yiu EM, Corben LA, Delatycki MB. A longitudinal study of the Friedreich Ataxia Impact Scale. J Neurol Sci. 2015;352(1–2):53–7.

Article  PubMed  Google Scholar 

Paulsen EK, Friedman LS, Myers LM, Lynch DR. Health-related quality of life in children with Friedreich ataxia. Pediatr Neurol. 2010;42(5):335–7.

Article  PubMed  Google Scholar 

Delmont E, Hiew FL, Cassereau J, et al. Determinants of health-related quality of life in anti-MAG neuropathy: a cross-sectional multicentre European study. J Peripher Nerv Syst. 2017;22(1):27–33.

Article  CAS  PubMed  Google Scholar 

Reetz K, Dogan I, Hilgers RD, et al. Progression characteristics of the European Friedreich’s Ataxia Consortium for Translational Studies (EFACTS): a 2 year cohort study. Lancet Neurol. 2016;15(13):1346–54.

Article  PubMed  Google Scholar 

Johnson NE, Heatwole CR, Dilek N, et al. Quality-of-life in Charcot-Marie-Tooth disease: the patient’s perspective. Neuromuscul Disord. 2014;24(11):1018–23.

Article  PubMed  PubMed Central  Google Scholar 

Félix E, Gimenes AC, Costa-Carvalho BT. Effects of inspiratory muscle training on lung volumes, respiratory muscle strength, and quality of life in patients with ataxia telangiectasia. Pediatr Pulmonol. 2014;49(3):238–44.

Article  PubMed  Google Scholar 

Brandsema JF, Stephens D, Hartley J, Yoon G. Intermediate-dose idebenone and quality of life in Friedreich ataxia. Pediatr Neurol. 2010;42(5):338–42.

Article  PubMed  Google Scholar 

Yap KH, Azmin S, CheHamzah J, Ahmad N, van de Warrenburg B, Mohamed IN. Pharmacological and non-pharmacological management of spinocerebellar ataxia: a systematic review. J Neurol. 2022;269(5):2315–37.

Article  PubMed  Google Scholar 

Corben LA, Collins V, Milne S, et al. Clinical management guidelines for Friedreich ataxia: best practice in rare diseases. Orphanet J Rare Dis. 2022;17(1):415.

Article  PubMed  PubMed Central  Google Scholar 

Xiong E, Lynch AE, Corben LA, et al. Health related quality of life in Friedreich ataxia in a large heterogeneous cohort. J Neurol Sci. 2020;410:116642.

Article  PubMed  Google Scholar 

Wilson CL, Fahey MC, Corben LA, et al. Quality of life in Friedreich ataxia: what clinical, social and demographic factors are important? Eur J Neurol. 2007;14(9):1040–7.

Article  CAS  PubMed  Google Scholar 

Graves TD, Cha YH, Hahn AF, et al. Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlation. Brain. 2014;137(Pt 4):1009–18.

Article  PubMed  PubMed Central  Google Scholar 

Santos LR, Teive HAG, Lopes Neto FDN, Macedo ACB, Mello NM, Zonta MB. Quality of life in individuals with spinocerebellar ataxia type 10: a preliminary study. Arq Neuropsiquiatr. 2018;76(8):527–33.

Article  PubMed  Google Scholar 

Kedar S, Ghate D, Murray EL, Corbett JJ, Subramony SH. Vision related quality of life in spinocerebellar ataxia. J Neurol Sci. 2015;358(1–2):404–8.

Article  PubMed  Google Scholar 

van Os NJH. Quality of life in ataxia-telangiectasia. Eur J Paediatr Neurol. 2022;40:A1.

Article  PubMed  Google Scholar 

Rönnefarth M, Hanisch N, Brandt AU, et al. Dysphagia affecting quality of life in cerebellar ataxia-a large survey. Cerebellum. 2020;19(3):437–45.

Article  PubMed  PubMed Central  Google Scholar 

Buesch K, Zhang R. A systematic review of disease prevalence, health-related quality of life, and economic outcomes associated with Friedreich’s Ataxia. Curr Med Res Opin. 2022;38(10):1739–49.

Article  PubMed  Google Scholar 

Bolzan G, Leotti VB, de Oliveira CM, et al. Quality of life since pre-ataxic phases of spinocerebellar ataxia type 3/Machado-Joseph disease. Cerebellum. 2022;21(2):297–305.

Article  PubMed  Google Scholar 

McGlashan HL, Blanchard CV, Luscombe C, et al. Quality of life and neurological disability in children and young people with ataxia telangiectasia. Eur J Paediatr Neurol. 2022;40:34–9.

Article  PubMed  Google Scholar 

Thordarson D, Silva J, Ouyang B, Bernard B, Hall D. Quality of life in fragile X-associated tremor/ataxia syndrome. Mov Disord Clin Pract. 2022;9(5):710–1.

Article  PubMed  PubMed Central  Google Scholar 

Diaféria G, Bommarito S, Braga Neto P, et al. Effect of speech therapy on quality of life in patients with spinocerebelar ataxia type 3. Arq Neuropsiquiatr. 2022;80(10):1017–25.

Article  PubMed  PubMed Central  Google Scholar 

Pérez-Flores J, Hernández-Torres A, Montón F, Nieto A. Health-related quality of life and depressive s